International Biotechnology Trust (IBT) Presentation at MELLO London November 2018
26 January 2019
By Carl Harald Janson, Lead Investment Manager, IBT
International Biotechnology Trust plc is an investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies, which may be quoted or unquoted and whose shares are considered to have growth prospects, with experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. It may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Investments may also be made in related sectors, such as medical devices and healthcare services. Its portfolio is split between large, mid and small-capitalization companies, primarily quoted on stock exchanges in North America. Its investment manager is SV Life Sciences Managers LLP.
Disclaimer and risk warning – 00:18
Agenda – 00:41
Video introducing IBT – 01:03
Management team – 03:50
SV Health Managers: The Manger of IBT – 04:18
Biotech is a high growth sector – 05:04
IBT dividend – 05:53
Growth drivers – 06:23
Risk: Politics in US and regulation – 09:28
Sector valuations at some of lowest in 20 yrs – 12:10
Performance of IBT – 12:47
Portfolio breakdown – 15:49
How to cope with pricing pressure and slow growth – 18:38
Portfolio changes – 19:09
Portfolio acquisitions in 17/18 – 19:47
Unquoted portfolio – 21:07
Investment process – 21:44
Risk mitigation – 22:52
Summary – 23:45
